Home » Glaxo May Not Launch Synflorix Vaccine in US
Glaxo May Not Launch Synflorix Vaccine in US
GlaxoSmithKline Plc may not launch its new pneumococcal vaccine Synflorix in the United States, opting for a different product instead, its chief executive said.
International Herald Tribune
International Herald Tribune
Upcoming Events
-
07May
-
14May
-
30May